Corporate Announcement Archives | Page 2 of 2

Ellume announces high-performance test for active COVID-19 infection

Highlights New high-performance antigen test for active COVID-19 infection, developed by Ellume, provides accurate results in less than 15 minutes Builds on existing QIAGEN partnership to bring another test to market to join the rapid, reliable COVID antibody test as announced last month Easy to use; each device can process over 30 samples per hour, […]

Ellume announces global partnership with QIAGEN for COVID-19 diagnosis

Highlights Ellume builds on existing partnership with global diagnostics company QIAGEN, to bring a rapid, reliable COVID antibody test to market QIAreach™ Anti-SARS-CoV-2 Total serology test has been submitted for US FDA Emergency Use Authorization 900,000 tests pre-ordered Brisbane, Australia – 25 August 2020 Digital diagnostics firm Ellume Ltd (Ellume or “the Company”) has extended […]

Ellume appoints Joanne Moss to its Board as Non-executive Director

Brisbane, Australia – 12 November 2019 Ellume Limited (Ellume) is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately. This appointment supports Ellume’s commitment to good governance and strengthens management resources in preparation for US commercialisation and potential upcoming […]

Ellume announces another global partnership with QIAGEN on the detection of tuberculosis

Highlights Australia’s Ellume Limited has partnered with QIAGEN N.V. to bring the next generation of latent TB testing to low-resource, high-burden countries The deal includes the licensing of Ellume technologies and a USD $15M minority investment by QIAGEN in Ellume Limited This announcement builds on the recent announcement of a global partnership with GlaxoSmithKline announced […]

Page 2 of 212

Scroll